'''Benzbromarone''' ([[International Nonproprietary Name|INN]]) is a [[uricosuric]] agent and non-competitive inhibitor of [[xanthine oxidase]]<ref>{{cite journal |pmid=1206675 |year=1975 |last1=Sinclair |first1=DS |last2=Fox |first2=IH |title=The pharmacology of hypouricemic effect of benzbromarone |volume=2 |issue=4 |pages=437–45 |journal=The Journal of rheumatology}}</ref> used in the treatment of [[gout]], especially when [[allopurinol]], a [[first-line treatment]], fails or produces intolerable [[adverse drug reaction|adverse effects]]. It is structurally related to the [[antiarrhythmic agent|antiarrhythmic]] [[amiodarone]].<ref name=Kumar>{{cite journal |doi=10.1124/dmd.106.010678 |title=Amiodarone Analog-Dependent Effects on CYP2C9-Mediated Metabolism and Kinetic Profiles |year=2006 |last1=Kumar |first1=V. |journal=Drug Metabolism and Disposition |volume=34 |issue=10 |pages=1688–96 |pmid=16815961 |last2=Locuson |first2=CW |last3=Sham |first3=YY |last4=Tracy |first4=TS}}</ref>

 
Benzbromarone is a very potent [[enzyme inhibitor|inhibitor]] of [[CYP2C9]].<ref name=Kumar/><ref>{{cite journal |doi=10.1124/mol.105.013763 |title=CYP2C9 Genotype-Dependent Effects on in Vitro Drug-Drug Interactions:  Switching of Benzbromarone Effect from Inhibition to Activation in the CYP2C9.3 Variant |year=2005 |last1=Hummel |first1=M. A. |journal=Molecular Pharmacology |pmid=15955872 |pmc=1552103 |volume=68 |pages=644–51}}</ref> Several [[analog (chemistry)|analogues]] of the drug have been developed as CYP2C9 and [[CYP2C19]] inhibitors for use in research.<ref>{{cite journal |doi=10.1021/bi049651o |title=Quantitative Binding Models for CYP2C9 Based on Benzbromarone Analogues† |year=2004 |last1=Locuson |first1=Charles W. |last2=Rock |first2=Denise A. |last3=Jones |first3=Jeffrey P. |journal=Biochemistry |volume=43 |issue=22 |pages=6948–58 |pmid=15170332}}</ref><ref>{{cite journal |doi=10.1021/jm049605m |title=Charge and Substituent Effects on Affinity and Metabolism of Benzbromarone-Based CYP2C19 Inhibitors |year=2004 |last1=Locuson |first1=Charles W. |last2=Suzuki |first2=Hisashi |last3=Rettie |first3=Allan E. |last4=Jones |first4=Jeffrey P. |journal=Journal of Medicinal Chemistry |volume=47 |issue=27 |pages=6768–76 |pmid=15615526}}</ref>
